Teaching Old Drugs New Tricks : Statins for COVID-19?
Copyright © 2020 Elsevier Inc. All rights reserved..
The COVID-19 pandemic has driven unprecedented efforts to identify existing treatments that can be quickly and effectively repurposed to reduce morbidity and mortality. In this issue of Cell Metabolism, Zhang et al. (2020) report an association between statin use and improved outcomes in a large observational study of hospitalized COVID-19 patients. Given the widespread availability, low cost, and safety of statins, this promising result should be further investigated in randomized controlled trials.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2020 |
---|---|
Erschienen: |
2020 |
Enthalten in: |
Zur Gesamtaufnahme - volume:32 |
---|---|
Enthalten in: |
Cell metabolism - 32(2020), 2 vom: 04. Aug., Seite 145-147 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Fajgenbaum, David C [VerfasserIn] |
---|
Links: |
---|
Themen: |
Hydroxymethylglutaryl-CoA Reductase Inhibitors |
---|
Anmerkungen: |
Date Completed 17.08.2020 Date Revised 18.12.2020 published: Print Citation Status MEDLINE |
---|
doi: |
10.1016/j.cmet.2020.07.006 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM313308128 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM313308128 | ||
003 | DE-627 | ||
005 | 20231225150309.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2020 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.cmet.2020.07.006 |2 doi | |
028 | 5 | 2 | |a pubmed24n1044.xml |
035 | |a (DE-627)NLM313308128 | ||
035 | |a (NLM)32755604 | ||
035 | |a (PII)S1550-4131(20)30364-8 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Fajgenbaum, David C |e verfasserin |4 aut | |
245 | 1 | 0 | |a Teaching Old Drugs New Tricks |b Statins for COVID-19? |
264 | 1 | |c 2020 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 17.08.2020 | ||
500 | |a Date Revised 18.12.2020 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2020 Elsevier Inc. All rights reserved. | ||
520 | |a The COVID-19 pandemic has driven unprecedented efforts to identify existing treatments that can be quickly and effectively repurposed to reduce morbidity and mortality. In this issue of Cell Metabolism, Zhang et al. (2020) report an association between statin use and improved outcomes in a large observational study of hospitalized COVID-19 patients. Given the widespread availability, low cost, and safety of statins, this promising result should be further investigated in randomized controlled trials | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, N.I.H., Extramural | |
650 | 7 | |a Hydroxymethylglutaryl-CoA Reductase Inhibitors |2 NLM | |
700 | 1 | |a Rader, Daniel J |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Cell metabolism |d 2005 |g 32(2020), 2 vom: 04. Aug., Seite 145-147 |w (DE-627)NLM156885433 |x 1932-7420 |7 nnns |
773 | 1 | 8 | |g volume:32 |g year:2020 |g number:2 |g day:04 |g month:08 |g pages:145-147 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.cmet.2020.07.006 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 32 |j 2020 |e 2 |b 04 |c 08 |h 145-147 |